|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
|
D12.776.422.220.453.499.500 |
|
|
22q11 Deletion Syndrome
|
C16.131.482.249 |
|
|
Garcinia kola
|
B01.650.940.800.575.912.250.859.625.333.400 |
|
|
Prospective Payment Assessment Commission
|
N03.219.521.710.305.200.605 |
|
|
Enviomycin
|
D12.644.641.875.250 |
|
|
Viomycin
|
D12.644.641.875 |
|
|
Hydroxylysine
|
D12.125.068.555.478 |
|
|
Pyridostigmine Bromide
|
D03.383.725.762.740 |
|
|
Chromosome Fragility
|
C23.550.362.180.180 |
|
|
Chromosomal Instability
|
C23.550.362.180 |
|
|
Hyaluronan Receptors
|
D12.776.395.550.200.625.144 |
|
|
Glucose Transporter Type 2
|
D12.776.543.585.500.500.750 |
|
|
Skin Manifestations
|
C23.888.885 |
|
|
Sample Size
|
N05.715.360.325.692 |
|
|
Adenoma, Chromophobe
|
C04.557.465.625.650.095 |
|
|
Muscle Hypertonia
|
C23.888.592.608.550 |
|
|
Meningitis, Pneumococcal
|
C10.228.228.180.500.875 |
|
|
Sesquiterpenes, Eudesmane
|
D02.455.849.765.674.500 |
|
|
Stellate Ganglion
|
A08.800.050.800.300.800 |
|
|
Immune Adherence Reaction
|
E01.370.225.812.400 |
|
